Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.

Education and Training in Autism and Developmental Disabilities is a prominent journal published by the Council for Exceptional Children, focusing on innovative research and insights in the field of autism and developmental disabilities education. With an evolving scope since its inception, the journal emphasizes the importance of evidence-based practices, pedagogical strategies, and interdisciplinary approaches to enhance educational outcomes for individuals with autism and related conditions. Although it currently holds a Q3 category in Developmental and Educational Psychology and is ranked in the Q2 category in Education, it continues to gain recognition with a respectable placement in Scopus rankings—indicating that it plays a crucial role in informing educational practices and policy decisions. Researchers and practitioners can access a wealth of information through its open access options, underscoring a commitment to disseminating knowledge widely. By bridging the gap between research and real-world application, this journal serves as an essential resource for education professionals seeking to advance their understanding and improve the quality of education for neurodiverse learners.

Pediatric Neurology, a prestigious journal published by Elsevier Science Inc, is a leading resource in the field of child neurology and developmental neurosciences. With an impressive impact factor and categorization in the Q1 and Q2 quartiles across several relevant fields, including Pediatrics, Neurology, and Developmental Neuroscience, this journal is essential for researchers and healthcare professionals focused on pediatric neurological disorders. Since its inception in 1985, it has provided a platform for high-quality research, clinical studies, and reviews that drive advancements in diagnosis, treatment, and understanding of neurological conditions in children. Although the journal does not currently offer open access, it maintains a robust reputation in the academic community, bolstered by its prominent ranking in Scopus metrics. By engaging with the latest findings published in Pediatric Neurology, readers will gain vital insights that contribute to improving pediatric healthcare outcomes in neurology and neuroscience.

AUTISM, published by SAGE Publications Ltd, is a leading journal in the field of Developmental and Educational Psychology, recognized for its significant contributions to understanding autism spectrum disorders. With an impressive impact factor, AUTISM ranks in the top 94th percentile among developmental and educational psychology journals, placing it in the prestigious Q1 quartile as of 2023. Since its inception in 1997, this UK-based journal has served as a vital resource for researchers, practitioners, and students, providing a platform for high-quality empirical research, reviews, and theoretical discussions that address contemporary challenges and advancements in autism research and practice. Readers can expect to find innovative studies that influence policy, education, and treatment methodologies, making AUTISM indispensable for those dedicated to enhancing the lives of individuals on the spectrum.

CoDAS, an esteemed academic journal published by the SOC BRASILEIRA FONOAUDIOLOGIA, serves as a leading platform for interdisciplinary research within the realms of linguistics, speech, and hearing sciences. Established as an Open Access journal in 2013, it ensures broad dissemination and accessibility of scholarly work, significantly benefitting researchers, clinicians, and students alike. Based in Brazil, CoDAS has garnered credibility with its impressive Q2 ranking in Linguistics and Language, as well as its rankings in Otorhinolaryngology and Speech and Hearing categories, reflecting its substantial contribution to these fields. The journal's impact is underscored by its robust Scopus rankings, including the 67th percentile in Language and Linguistics. With a commitment to fostering innovative research and bridging gaps between theory and practice, CoDAS continues to play a vital role in advancing knowledge and clinical practices in communication disorders and auditory sciences.

BEHAVIOR MODIFICATION, published by SAGE PUBLICATIONS INC, is a prestigious journal dedicated to advancing the study and practice of behavior modification across various disciplines. With a robust ISSN of 0145-4455 and an E-ISSN of 1552-4167, this journal has established itself as a vital resource for researchers and practitioners since its inception in 1977. Recognized for its academic rigor, it is classified in the Q1 quartile for Arts and Humanities and Q2 in Clinical Psychology, as well as Developmental and Educational Psychology for 2023, showcasing its influence and relevance in these fields. The journal's Scopus rankings further exhibit its high standing, with 90th percentile in Arts and Humanities and 75th percentile in both development and clinical psychology categories. Although it is not an open-access journal, it provides essential insights and comprehensive research aimed at promoting evidence-based practices and innovative interventions in behavior modification. With a commitment to fostering interdisciplinary collaboration, BEHAVIOR MODIFICATION serves as an essential platform for researchers, professionals, and students seeking to enhance their understanding of behavioral principles to impact individual lives positively.

Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

The International Journal of Developmental Disabilities, published by Taylor & Francis Ltd, serves as a premier platform for cutting-edge research in the field of developmental disabilities. With an ISSN of 2047-3869 and an E-ISSN of 2047-3877, this journal caters to a global academic audience, exploring relevant topics across Developmental and Educational Psychology and Psychiatry and Mental Health, as reflected in its 2023 Q3 quartile rankings. With a publication history dating back to 2012 and spanning to 2024, this journal is committed to advancing the understanding of developmental disorders and promoting evidence-based practices. Researchers, educators, and clinicians will find invaluable insights through open-access articles that address critical issues, therapeutic interventions, and policy discussions. Located in the United Kingdom at 2-4 Park Square, Milton Park, Abingdon, the International Journal of Developmental Disabilities stands as an essential resource for fostering academic dialogue and innovation in this vital area of study.

Current Developmental Disorders Reports, published by SPRINGERNATURE, is a crucial resource for researchers, practitioners, and students in the fields of developmental psychology, psychiatry, and neuroscience. Since its inception in 2014, this journal has aimed to disseminate cutting-edge research on the multifaceted nature of developmental disorders, providing valuable insights into causation, diagnosis, and intervention strategies. With an E-ISSN of 2196-2987 and a notable standing in the Q3 quartile across multiple fields—developmental and educational psychology, developmental neuroscience, and psychiatry and mental health—this journal holds a significant position in the academic landscape. Researchers contributing to the journal benefit from its open access policies, stimulating knowledge sharing and dialogue within the scientific community. The journal’s commitment to advancing understanding in these critical areas of study is reflected in its rigorous publication standards and diverse range of articles, making it an essential read for anyone invested in the developments in mental health and developmental disorders.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.